Skip to main content
. 2004 Aug;63(8):974–981. doi: 10.1136/ard.2003.011205

Figure 2.

Figure 2

 Evaluation of vital capacity (VC) in patients with severe systemic sclerosis before inclusion (n = 47) and then at 6 (n = 26), 12 (n = 27), 24 (n = 18), and 36 (n = 10) months after HSCT. There was no significant deterioration for each patient when calculated at the available point compared with the baseline measurement using the Wilcoxon signed rank test (NS).